1. Home
  2. ALVR vs SPRU Comparison

ALVR vs SPRU Comparison

Compare ALVR & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • SPRU
  • Stock Information
  • Founded
  • ALVR 2013
  • SPRU 2008
  • Country
  • ALVR United States
  • SPRU United States
  • Employees
  • ALVR N/A
  • SPRU N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • SPRU Auto Parts:O.E.M.
  • Sector
  • ALVR Health Care
  • SPRU Consumer Discretionary
  • Exchange
  • ALVR Nasdaq
  • SPRU Nasdaq
  • Market Cap
  • ALVR 46.6M
  • SPRU 47.4M
  • IPO Year
  • ALVR 2020
  • SPRU N/A
  • Fundamental
  • Price
  • ALVR $9.38
  • SPRU $2.90
  • Analyst Decision
  • ALVR
  • SPRU
  • Analyst Count
  • ALVR 0
  • SPRU 0
  • Target Price
  • ALVR N/A
  • SPRU N/A
  • AVG Volume (30 Days)
  • ALVR 29.1K
  • SPRU 59.6K
  • Earning Date
  • ALVR 03-14-2025
  • SPRU 03-13-2025
  • Dividend Yield
  • ALVR N/A
  • SPRU N/A
  • EPS Growth
  • ALVR N/A
  • SPRU N/A
  • EPS
  • ALVR N/A
  • SPRU N/A
  • Revenue
  • ALVR N/A
  • SPRU $77,582,000.00
  • Revenue This Year
  • ALVR N/A
  • SPRU $1.54
  • Revenue Next Year
  • ALVR N/A
  • SPRU $3.40
  • P/E Ratio
  • ALVR N/A
  • SPRU N/A
  • Revenue Growth
  • ALVR N/A
  • SPRU N/A
  • 52 Week Low
  • ALVR $7.96
  • SPRU $2.17
  • 52 Week High
  • ALVR $24.15
  • SPRU $4.89
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 39.33
  • SPRU 51.99
  • Support Level
  • ALVR $7.96
  • SPRU $2.71
  • Resistance Level
  • ALVR $10.00
  • SPRU $2.94
  • Average True Range (ATR)
  • ALVR 1.14
  • SPRU 0.18
  • MACD
  • ALVR 0.03
  • SPRU -0.03
  • Stochastic Oscillator
  • ALVR 35.50
  • SPRU 36.54

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is a leading owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to approximately 75,000 home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's primary customers are homeowners and the Company's core solar service offerings generate revenues primarily through (i) the sale of electricity generated by its home solar energy systems to homeowners, (ii) third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and (iii) the servicing of those agreements for other institutional owners of home solar energy systems.

Share on Social Networks: